Back to News
Market Impact: 0.3
CVS Health Corporation Reports Third Quarter 2026 Results and Raises Full-Year 2026 Guidance
Source: Nasdaq
Corporate EarningsCompany FundamentalsHealthcare & Biotech
CVS Health reported third-quarter revenue of $108.4 billion, up 5.4% year over year. GAAP diluted EPS was $1.68, compared with a loss of $3.13 per share a year earlier; the article attributes the change in part to the absence of a prior-year $5.7 billion item, but the provided text cuts off before identifying it.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.30
Ticker Sentiment
CVS0.65
More News
- Why we're kicking CVS out of our Bullpen watchlist. Plus, Intel's CEO makes a stand
- CVS Plans to Break Up $117 Billion Healthcare Conglomerate
- How Abdul El-Sayed would build Medicare for All, from a wealth tax to a Fed-style governing board
- How CVS built a healthcare empire it now plans to split
- CVS Health to split in two, separating pharmacy business from insurance
- Evercore ISI maintains CVS Health stock rating amid spinoff reports